CIDRAP newsletters options
The outbreak has grown to 63 cases, up from 50 cases 3 days ago.
New WHO data show that cases and deaths remained steady in 2021, easing worries about the impact of COVID-19 disruptions.
The country has received 1,200 doses of a candidate Sudan Ebola vaccine from the WHO.
Amid rising cases, eased restrictions come with intensified efforts to vaccinate seniors.
A total of 22,006 adverse outcomes occurred, mostly in patients who took metformin before COVID-19 diagnosis (37.1%), while 19.5% each had used insulin or DPP-4is.
Swedish study shows ICU patients most likely to experience long COVID.
The bivalent booster marshaled a robust antibody response against the Omicron BA.4/BA.5 subvariants but not against the more recently emerged variants.
A trial in Ethiopia suggests mass azithromycin distribution to wide, contiguous areas may reduce the likelihood of the infection that causes trachoma.
Officials report more highly pathogenic avian flu outbreaks at commercial turkey farms in Iowa and South Dakota.
Minorities were underrepresented in both COVID-19 clinical treatment trials and in disease prevention trials.
Rebound was uncommon after use of the oral antivirals Paxlovid and molnupiravir to lower the risk of severe outcomes.
Groups representing infectious disease and public health professionals and the pharmaceutical industry are trying to push a bill across the finish line that could change the antibiotic development landscape.
Protection was 35% among those vaccinated before contracting COVID-19.
Many mpox infections have been reported in healthcare workers, but only a few were due to occupational exposure.
Despite the milestone, funding remains far short of what's needed, according to a new report.
Americans with ADHD are struggling to find good alternatives to the stimulant Adderall.
Eight infections in travelers returning from affected areas have been reported in the US.
The detection lifts the number of states that have reported outbreaks in poultry this year to 47.
Amid rising flu activity causing decade-high hospitalization rates, COVID-19 markers are also climbing.
Symptoms overall declined in a year, but some had symptoms for the first time at 6 and 12 months.
